Family · Pharmaceutical analytical standards
Raltegravir
An HIV antiretroviral, the first integrase inhibitor to be approved, in 2007: it stops the virus from inserting its genetic material into the DNA of human cells. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?The suffix '-tegravir', now shared by elvitegravir, dolutegravir, bictegravir and cabotegravir, marks the integrase inhibitors, after the enzyme that 'pastes' viral DNA into the cell's own.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
